Liu, Long <br/><br/>
ncRuPAR inhibits gastric cancer progression by down-regulating protease-activated receptor-1.  [electronic resource] 

 -  Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine  Aug 2014 
 - 7821-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0380 
<br/><br/><label>Standard No.: </label>10.1007/s13277-014-2042-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Disease Progression<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>RNA, Long Noncoding--physiology<br/>ROC Curve<br/>Receptor, PAR-1--genetics<br/>Stomach Neoplasms--pathology<br/>Vascular Endothelial Growth Factor A--analysis<br/>Platelet Aggregation Inhibitors